|
FY2026
12 months to Mar 29, 2026
|
FY2025
12 months to Mar 30, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Apr 2, 2023
|
FY2022
12 months to Apr 3, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of products sold | |||||
| Gross profit | |||||
| Marketing and administrative expenses | |||||
| Goodwill impairment charge | |||||
| Income (loss) from operations | |||||
| Other income (expense): | |||||
| Interest expense - net of interest income | |||||
| Gain on insurance proceeds received for damage to equipment | |||||
| Loss on sale of property, plant and equipment | |||||
| Other income (expense) - net | |||||
| Income (loss) before income tax expense | |||||
| Income tax expense (benefit) | |||||
| Segment net income (loss) | |||||
| Weighted average shares outstanding: | |||||
| Basic (in shares) | |||||
| Effect of dilutive securities (in shares) | |||||
| Diluted (in shares) | |||||
| Basic earnings (loss) per share (in dollars per share) | |||||
| Diluted earnings (loss) per share (in dollars per share) | |||||
Loading...